Overview

Dapagliflozin Therapy In Cardiac Surgery

Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
This randomized controlled trial is to assess the effects of perioperative dapagliflozin on type 2 diabetic patients undergoing cardiac surgery
Phase:
Phase 4
Details
Lead Sponsor:
China National Center for Cardiovascular Diseases
Treatments:
Dapagliflozin